Citation: Sj. Mistry et al., Development of ribozymes that target stathmin, a major regulator of the mitotic spindle, ANTISENSE N, 11(1), 2001, pp. 41-49
Citation: Gf. Atweh et An. Schechter, Pharmacologic induction of fetal hemoglobin: raising the therapeutic bar in sickle cell disease, CURR OPIN H, 8(2), 2001, pp. 123-130
Citation: Gf. Atweh et D. Loukopoulos, Pharmacological induction of fetal hemoglobin in sickle cell disease and beta-thalassemia, SEM HEMATOL, 38(4), 2001, pp. 367-373
Citation: Sj. Mistry et Gf. Atweh, Stathmin inhibition enhances okadaic acid-induced mitotic arrest - A potential role for stathmin in mitotic exit, J BIOL CHEM, 276(33), 2001, pp. 31209-31215
Citation: C. Iancu et al., Taxol and anti-stathmin therapy: A synergistic combination that targets the mitotic spindle, CANCER RES, 60(13), 2000, pp. 3537-3541
Authors:
Hosono, S
Luo, X
Hyink, DP
Schnapp, LM
Wilson, PD
Burrow, CR
Reddy, JC
Atweh, GF
Licht, JD
Citation: S. Hosono et al., WT1 expression induces features of renal epithelial differentiation in mesenchymal fibroblasts, ONCOGENE, 18(2), 1999, pp. 417-427
Authors:
Sutton, M
Atweh, GF
Cashman, TD
Davis, WT
Citation: M. Sutton et al., Resolving conflicts: Misconceptions and myths in the care of the patient with sickle cell disease, MT SINAI J, 66(4), 1999, pp. 282-285
Authors:
Atweh, GF
Sutton, M
Nassif, I
Boosalis, V
Dover, GJ
Wallenstein, S
Wright, E
McMahon, L
Stamatoyannopoulos, G
Faller, DV
Perrine, SP
Citation: Gf. Atweh et al., Sustained induction of fetal hemoglobin by pulse butyrate therapy in sickle cell disease, BLOOD, 93(6), 1999, pp. 1790-1797